Riskpilot← Back to searchSign inGet full accessPHARMATRADE EJENDOMME A/S
A/SIn liquidationCVR 54556314Skaaremosevej 11Rental and operating of own or leased real estate · NACE 6820Est. 1976— employees
Revenue 2016
DKK 26K
-84% vs 2015
EBITDA margin
-220.2%
-135% vs 2015
Equity ratio
2.4%
Financial strength
Net profit 2016
DKK 154K
+309% vs 2015
| Revenue | DKK 26K | -84% |
| EBITDA | DKK -56K | -135% |
| Net profit | DKK 154K | +309% |
| Total assets | DKK 12,1M | -12% |
| Equity | DKK 296K | +4% |
| Employees | — | — |
Legal name
PHARMATRADE EJENDOMME A/S
CVR number
54556314
Legal form
Aktieselskab
NACE code
6820 · Rental and operating of own or leased real estate
Founded
12. april 1976
Share capital
DKK 500.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2016-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Skaaremosevej 11
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Revenue | 300 | 300 | 260 | 160 | 26 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 266 | 9 | 260 | 160 | -56 |
| Depreciation & amort. | -89 | -89 | -89 | -401 | -0 |
| EBIT | 178 | -80 | 172 | -241 | -56 |
| Net financials | -76 | -309 | -445 | 227 | 219 |
| Profit before tax | 101 | -389 | -273 | -14 | 163 |
| Tax | 25 | -174 | -64 | -51 | 9 |
| Net profit | 76 | -215 | -210 | 38 | 154 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Total assets | 4.249 | 15.582 | 14.704 | 13.728 | 12.122 |
| Equity | 1.979 | 1.764 | 892 | 284 | 296 |
| Long-term debt | 1.417 | 1.315 | 75 | 75 | 0 |
| Short-term debt | 255 | 11.993 | 13.218 | 13.149 | 11.825 |
| Total debt | 1.672 | 13.308 | 13.293 | 13.224 | 11.825 |
EBITDA margin
-220.2%
This company
15.8%
Market median
-1494% vs market
20122016
Equity ratio
2.4%
This company
38.2%
Market median
-94% vs market
20122016
Return on equity
51.9%
This company
18.4%
Market median
+182% vs market
20122016
Net profit margin
599.2%
This company
8.1%
Market median
+7298% vs market
20122016
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122016
Debt / equity
39.91×
This company
0.62×
Market median
-6337% vs market
20122016
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JO Chief Executive Officer | Chief Executive Officer | 2003 | — | — |
JV Management | Management | 1976 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1976 | — | — | |
| Board of Directors | 1976 | — | — | |
| Board of Directors | 2001 | — | — | |
| Board of Directors | 2003 | — | — | |
| Board of Directors | 2003 | — | — | |
| Board of Directors | 1976 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PHARMA-TRADE A/S | Company | 100.0% | 100.0% | 2003 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PHARMATRADE EJENDOMME A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Overgaard | Chief Executive Officer | 0 companies |
| Jens Vagn Nielsen | Management | 0 companies |
| Steen Honoré Hansen | Board of Directors | 0 companies |
| Mogens Axel Gelardi Kalsbøll | Board of Directors | 0 companies |
| Karsten Kielland | Board of Directors | 0 companies |
| Henrik Overgaard | Board of Directors | 0 companies |
| Ib Preben Overgaard | Board of Directors | 0 companies |
| Benny Ole Grath | Board of Directors | 0 companies |